Home › IncellDx Signs Agreement With Bristol-Myers Squibb Related To The Development Of An Assay For A Companion Diagnostic Test
 

Keywords :   


IncellDx Signs Agreement With Bristol-Myers Squibb Related To The Development Of An Assay For A Companion Diagnostic Test

2013-10-30 05:49:33| drugdiscoveryonline News Articles

IncellDx, Inc. announced today that they have entered into an agreement with Bristol-Myers Squibb Company (NYSE:BMY) related to the development of an assay for potential application in a molecular companion diagnostic intended to identify patients likely to benefit from treatment with a Bristol-Myers Squibb drug that is currently under development

Tags: related development test agreement

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
More »